Life sciences suffered post-Covid after rallying during Covid. WAT is a major player. Last Wednesday they reperted a clean top/bottom line beat, but issued a cautious earnings forecast, so the market gave a muted reaction. Likes them, because they have few competitors at at time when the economy is slowing down.
They thrived during Covid, because people wore informal-wear, but then got killed after Covid. It bottomed last summer, but recovered 170% since then and 15% YTD. They bought the Hey Dude brand, which helped. They reported an excellent quarter last Thursday.